Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
2-Amino-3,4-dimethylbenzoic Acid is an intermediate used in the synthesis of vadimezan, a tumor-vascular disrupting agent that attacks blood supply of cancerous tumor cells and causes tumor regression.